Article Details

Pfizer's Hospira escapes adrenaline patent claims based on PTO omissions | Reuters

Retrieved on: 2021-09-01 23:26:15

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Hospira escapes adrenaline patent claims based on PTO omissions | Reuters. View article details on hiswai:

Excerpt

(Reuters) - A Pfizer unit's win against Belcher Pharmaceuticals' claims that its adrenaline shot Abboject infringed a Belcher adrenaline patent was upheld ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up